Finalists of the ACHEMA Start-up Award selected

More than 30 start-ups had applied for the ACHEMA Start-Up Award. Based on their business plans, ten of them were selected that showed both a high degree of innovation and a very convincing business model. They will showcase their technologies to the global expert community at ACHEMA Pulse and in a pitch on 15 June 2021. An expert jury will select later in a special session the three winners of the competition. They will be announced at ACHEMA in April 2022 and receive 10,000 Euro prize money each.

And these are the finalists:

• Carbon Minds is a data analytics startup. It uses a proprietary digital model of the global chemicals and plastics industry to offer its clients transparency about environmental impacts in global supply chains.
   
• Cenios is focused on development of next generation of POCT-Kits (Point-of-Care-Teste) for absolute quantification of analytes. the kits will be used as an alternative methods for therapeutic drug monitoring (TDM) and can significantly reduce the cost and time of clinical measurements.
   
• ESy-Labs GmbH is a pioneer in electrifying the chemical industry, developing processes for the electrosynthesis of organic chemicals based on high-throughput screening and artificial intelligence.
   
• Lumatix Biotech seeks to improve the availability and affordability of antibody products by developing a light-controlled affinity matrix as a superior alternative to Protein A chromatography.
   
• Phaidra creates AI-powered control systems for industrial processes. Its no-code software enables domain experts to specify which performance metrics they want to optimize, along with the operating parameters.
   
• PipePredict offers precise digital leakage localization, predictive maintenance and real-time monitoring of pipe networks by analyzing existing sensor data with a digital twin and AI algorithms.
   
• PRAMOMOLECULAR has developed a particularly simple technology with which therapeutic oligonucleotides such as siRNAs can be transported efficiently and tolerably into the target cell in order to silence disease-causing proteins in the lungs, heart or pancreas.
   
• Pro-AspectX is developing a plug and play, non-invasive sensor to improve chemical, biotechnological and life science processes to highest possible efficiency, simultaneously raising the process safety by a forecast of critical situations.
   
• PROSION develops a first-in-class approach to address so far undruggable pharmaceutical targets that are linked with various hard-to-treat diseases through a disruptive platform of chemical building blocks called ProMs.
   
• Semodia offers software solutions for the modularisation of the process industry, transferring the ""Plug-&Play""-principle of office hardware via module type packages into the process industry.

Entrepreneurial scientists, future founders and owners of start-ups were invited for the third time to apply for the ACHEMA Start-Up Award.

The ACHEMA Start-Up Award is organized by DECHEMA Gesellschaft für Chemische Technik und Biotechnologie e.V.,  DECHEMA Ausstellungs-GmbH,  Business Angels FrankfurtRheinMain and High-Tech Gründerfonds. Clariant supports the award as a premium partner. The ACHEMA Start-Up Award is also supported by Gesellschaft Deutscher Chemiker (GDCh), Verein Deutscher Ingenieure (VDI),  Verband der Chemischen Industrie (VCI) and AiF FTK as well as Business Angels Netzwerk Deutschland.

More information